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Edited by Maurice MontalAbstract Vascular endothelial growth factor (VEGF), a potent
mitogen for vascular endothelial cells, has been suggested as a
modulator that is involved in neurogenesis as well as angiogene-
sis. Here, we directly examined the eﬀect of VEGF on neuroec-
todermal diﬀerentiation using human embryonic stem cells
(hESCs). VEGF treatment upregulated the expression of neuro-
ectodermal genes (Sox1 and Nestin) during germ layer formation
in embryoid bodies (EBs) and eﬃciently increased the number of
neural rosettes expressing both Pax6 and Nestin. The neural
progenitors generated from VEGF-treated EBs further diﬀeren-
tiated into cells that showed a similar pattern of gene expression
observed in the development of dopaminergic neurons upon ter-
minal diﬀerentiation. These results support the neurogenic eﬀect
of VEGF on hESC diﬀerentiation.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Neurons1. Introduction
Human embryonic stem cells (hESCs) are an attractive sys-
tem for the study of human development and may be a source
of cells for cell replacement therapies. Although the generation
of clinically relevant neural cell types from hESCs has been
exploited in many studies [1,2], relatively little is known about
the early inductive event between neuroectodermal cells and
other cell types during in vitro diﬀerentiation of hESCs. Many
studies of vertebrate development show that multiple inductive
signals that pass between diﬀerent tissues and organs play
important roles in linking cell type diﬀerentiation to organo-
genesis [3]. For example, the liver rudiment arises from deﬁn-
itive foregut endoderm by convergent FGF and BMP signals
from the cardiac mesoderm and the septum transversum mes-
enchyme [4]. In addition, an early induction of the neuroecto-
derm and subsequent patterning of the neural tube are known*Corresponding author. Present address: Building 1/Room 304,
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doi:10.1016/j.febslet.2006.09.053to be regulated by various inducing factors produced by sur-
rounding tissues, including the epidermal ectoderm, noto-
chord, and somites [5–7].
Previous studies have demonstrated that vascular endothelial
growth factor (VEGF), an angiogenic peptide known to stimu-
late endothelial cell proliferation, promotes proliferation, sur-
vival, and axonal outgrowth of nerve cells [8–12]. Conversely,
other reports have shown that nerve growth factor (NGF), a
neurotrophin known to regulate neuronal growth and survival,
stimulates de novo vascularization [13]. Furthermore, a recent
developmental study demonstrated in vitro and in vivo that
the neural tube promoted vascular plexus formation via the
VEGF signaling pathway, suggesting that the neural tube is a
midline signaling center for embryonic vascular pattern forma-
tion [14]. These ﬁndings thus suggest the presence of reciprocal
paracrine control between nerves and vascular cells.
Here, we directly tested the eﬀect of VEGF on neuroectoder-
mal diﬀerentiation of hESCs by using an in vitro system to
generate embryoid bodies (EBs), which are thought to mimic
early embryonic development. Our data demonstrate that
hESCs can diﬀerentiate into all three embryonic germ layers
(endoderm, mesoderm, and ectoderm) and extra-embryonic
cell types of the gastrula during EB formation. In addition,
VEGF treatment during this stage can promote the diﬀerenti-
ation of hESCs into the neuroectoderm that give rise to large
numbers of neurons with dopaminergic phenotypes.2. Materials and methods
2.1. hESC culture and neural diﬀerentiation
hESCs (Miz-hES4 and Miz-hES6) were grown as previously de-
scribed [15]. To induce EB formation, hESC colonies were harvested
upon treatment with 2 mg/ml collagenase type IV (Invitrogen, Carls-
bad, CA), gently triturated, and transferred to suspension culture
dishes (Corning, Corning, NY) at a speciﬁc density (2 · 105 cells/ml)
without bFGF. The hESC clumps were then cultured with or without
VEGF (50 ng/ml, R&D Systems, Minneapolis, MN) for 8 days to form
simple EBs. The culture medium supplemented with VEGF was chan-
ged every other day. Human EBs (hEBs) were then plated onto tissue
culture dishes in ITS medium [16] containing ﬁbronectin (Sigma, St.
Louis, MO). Over the span of 8 days, cells exhibiting the morphology
of neuroepithelial cells were observed and rosette formation was visu-
alized in the diﬀerentiating hEBs. To obtain a large number of neural
progenitor cells, diﬀerentiating cells from hEBs were dissociated and
plated onto polyornithine (15 lg/ml, Sigma)-coated plates at a density
of 1 · 105 cells/cm2 in N2 medium [16] containing 20 ng/ml of bFGF.
After 6–8 days of propagation, the cells were terminally diﬀerentiated
in N2 medium without bFGF for 6–10 days. The schematic procedure
of diﬀerentiation is shown in Fig. 5A.blished by Elsevier B.V. All rights reserved.
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Cells were ﬁxed in 4% paraformaldehyde in phosphate-buﬀered sal-
ine (PBS). hEBs were ﬁxed in 4% paraformaldehyde, transferred to
20% sucrose, frozen in O.C.T. compound (Tissue Tek, Sakura,
Japan) and sectioned at 10 lm. Immunostaining was carried out using
standard protocols, and alkaline phosphatase activity was analyzed
using Alkaline Phosphatase Substrate Kit III (Vector Laboratories,
Burlingame, CA) as recommended by the manufacturer. Primary anti-
bodies against the following proteins or neurotransmitters were used
for immunostaining: Oct4 (Santa Cruz Biotechnology, Santa Cruz,
CA); Nanog (R&D Systems); SSEA4 (R&D Systems); GATA4 (Santa
Cruz Biotechnology); Sox17 (R&D Systems); Foxa2 (Santa Cruz Bio-
technology); Brachyury (R&D Systems); Pax6 (Chemicon, Temecula,
CA); Nestin (R&D systems); a-fetoprotein (AFP) (Sigma); tyrosine
hydroxylase (TH) (Sigma); TuJ1 (R&D Systems); c-aminobutyric acid
(GABA) (Sigma); glial ﬁbrillary acidic protein (GFAP) (MP Biomed-
icals, Aurora, OH); CD34 (Novocastra, Newcastle, UK). Appropriate
ﬂuorescence-tagged secondary antibodies (Molecular Probes, Eugene,
OR) were used for visualization. Quantitative evaluation was per-
formed by counting neural rosettes or immunolabeled cells. Values
were expressed as means ± S.E.M. Student’s t-test was used to deter-
mine statistical signiﬁcance.Fig. 1. Characterization of undiﬀerentiated hESCs. Representative
images for phase-contrast morphology (A) and alkaline phosphatase
activity (B) of undiﬀerentiated hESCs. The inset in (A) shows a high
nucleus-to-cytoplasm ratio of hESCs. Immunostaining shows the
expression of Oct4 (C), Nanog (C, inset), and SSEA4 (D) in hESCs.
Scale bars: 100 lm.2.3. RNA extraction and RT-PCR analysis
Total RNA was isolated using Trizol (Invitrogen) and cDNA was
synthesized from 2 lg of total RNA using the SuperScript III
First-Strand Synthesis Kit (Invitrogen) as recommended by the manu-
facturer. Subsequent polymerase chain reactions were carried out using
AccuPower PCR-Premix (Bioneer). PCR analysis was performed
with the following primers: Nestin: 5 0-cagctggcgcacctcaagatg-30,
5 0-agggaagttgggctcaggactgg-3 0; Sox1: 5 0-caatgcggggaggagaagtc-3 0, 5 0-
ctctggaccaaactgtggcg-30; Pax6: 5 0-ccgagagtagcgactccag-30, 5 0-cttccgg-
tctgcccgttc-30; GATA4: 5 0-atgggacgggtcactatctg-3 0, 5 0-ctgtgcccgtgag-
ataa-30; Foxa2: 5 0-ctacgccaacatgaactcca-30, 5 0-aaggggaagaggtccatgat-
3 0; Sox17: 5 0-agcgcccttcacgtgtacta-3 0, 5 0-cttgcacacgaagtgcagat-3 0;
Mixl1: 5 0-ggtaccccgacatccactt-30, 5 0-tgagtccagctttgaaccaa-3 0; Brachy-
ury: 5 0-taaggtggatcttcaggtagc-3 0, 5 0-catctcattggtgagctccct-30; Nurr1:
5 0-gcacttcggcagttgaatga-30, 5 0-ggtggctgtgttgctggtagtt-3 0; Engrailed-1
(En1): 5 0-ctgggtgtactgcacacgttat-3 0, 5 0-tactcgctctcgtctttgtcct-30; TH:
5 0-gtcccctggttcccaagaaaagt-30, 5 0-tccagctgggggatattgtcttc-3 0; aromatic
L-amino acid decarboxylase (AADC): 5 0-ctcggaccaaagtgatccat-30,
5 0-gggtggcaaccataaagaaa-3 0; dopamine b-hydroxylase (DbH): 5 0-gca-
gatctcgtggtgctct-3 0, 5 0-agcagggtcaggccttct-3 0; glyceraldehydes-3-phos-
phate dehydrogenase (GAPDH): 5 0-agccacatcgctcagacacc-3 0, 5 0-
gtactcagcggccagcatcg-30.2.4. In situ detection of apoptosis
Apoptosis was detected at day 8 of EB formation using the terminal
deoxynucleotidyl transferase mediated d-UTP nick end-labeling (TU-
NEL) method. TUNEL was performed using an in situ Cell Death
Detection Kit (Roche, Penzberg, Germany) according to the manufac-
turer’s instructions, followed by immunostaining with antibodies
against Pax6 or Nestin. The numbers of TUNEL-positive cells express-
ing Nestin or Pax6 were counted, scoring at least 10000 cells in ﬁve
microscopic ﬁelds randomly selected in each group (n = 5).2.5. Statistical analysis
The values are expressed as means ± S.E.M. For the determination
of statistical signiﬁcance, Student’s t-tests were performed. P-values
less than 0.05 were considered signiﬁcant.3. Results and discussion
3.1. Diﬀerentiation into cell types of the gastrula
For the results of this study to have general signiﬁcance, it is
important to establish that the starting cells are undiﬀerenti-
ated and retain the characteristics of hESCs. Phase-contrast
photographs demonstrated that hESCs used in the present
study formed relatively ﬂat, compact colonies with well-de-
ﬁned edges (Fig. 1A), and individual cells had a high ratio ofnucleus to cytoplasm (Fig. 1A, inset). Immunostaining and
gene expression analyses also revealed that the hESCs ex-
pressed Oct4, Nanog, SSEA4, and alkaline phosphatase, which
indicates that the initial population consisted of undiﬀerenti-
ated ESCs (Fig. 1B–D).
The strategy used to diﬀerentiate hESCs in our system was
to ﬁrst allow the cells to form aggregates, hEBs. It is known
that, during the ﬁrst 4 days in suspension, mouse ESCs form
cell aggregates termed ‘simple EBs’, which resemble the 5- to
6-day-old mouse embryo [17]. Because hESCs divide more
slowly than mouse ESCs, the duration of the EB formation
was extended from 4 days to 8 days in the present study.
EBs were readily generated from control- and VEGF-treated
cultures (200–250 EBs), and there was no signiﬁcant diﬀer-
ences in the eﬃciency of EB formation between these two con-
ditions.
During embryogenesis, the loss of Foxa2 or Sox17 activity
results in the loss of deﬁnitive gut endoderm [18,19]. Immuno-
staining analysis of frozen hEB sections showed that Foxa2+
cells were found in gut tube-like structures (Fig. 2A), and the
majority, but not all, of the cells expressing Foxa2 were found
to coexpress Sox17 (Fig. 2A, inset). The presence of deﬁnitive
endoderm was supported by additional immunostaining using
anti-GATA4 antibody. GATA4 is known to be expressed in
deﬁnitive endoderm and plays an essential role in gut closure
and foregut formation [20]. Although GATA4+ cells were
rarely found in hEBs, some of the EBs contained GATA4+
cells in the center as a multilayered structure (Fig. 2B).
Although GATA4 is also expressed in cardiac mesoderm
[21], nearly all of the GATA4+ cells in these structures were la-
beled with an antibody against Sox17, indicating the genera-
tion of endoderm rather than mesoderm (Fig. 2B, inset).
Although primitive and deﬁnitive endoderm share multiple
markers, including Sox17, GATA4, and Foxa2 [19,22,23],
primitive endoderm was easily distinguished because it was lo-
cated at the outer cell layer of EBs and expressed GATA4, to-
gether with AFP, a marker of mouse and human visceral
Fig. 2. Immunostaining and RT-PCR analysis of hEBs for the expression of markers associated with the early embryonic and extra-embryonic
tissues. (A, B) hESC-derived deﬁnitive endodermal cells expressed Foxa2 (A) and Sox17 (A, inset), and also coexpressed GATA4 (B) and Sox17 (B,
inset). (C) Primitive endodermal cells in the outer cell layer of hEBs expressed GATA4 and AFP. (D) Brachyury+ cells in EBs represented
mesodermal diﬀerentiation. (E–I) Neuroectodermal diﬀerentiation of hESCs. A subset of the cells in the hEB formed a neural rosette expressing Pax6
(E), and rosettes expressing both Pax6 and Nestin were found at diﬀerent areas within hEBs (F–I). (J) Expression analyses of hEBs for the genes
expressed in the early embryonic germ layers. Each of these micrographs was chosen as representative from at least three independent experiments.
Scale bars: 100 lm.
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examined by the expression of Brachyury, a T-box transcrip-
tion factor that is expressed in the primitive streak and is
thought to play a critical role in the diﬀerentiation of meso-
derm during gastrulation [25]. Brachyury+ cells were easily
seen as clusters in hEBs (Fig. 2D), but Brachyury/GATA4
double-positive cells were rarely observed (data not shown).
Early neuroectodermal cells express transcription factors,
Pax6 [26] and Sox1 [27], and the intermediate ﬁlament protein
Nestin [28]. As shown in Fig. 2E, a subset of cells in hEBs ex-
pressed Pax6, and cells expressing both Pax6 and Nestin were
primarily found in neural tube-like structures, called neural
rosettes, at diﬀerent areas within the hEBs (Fig. 2F–I). In vitro
development of the embryonic germ layers in hEBs was further
conﬁrmed by RT-PCR analyses for a panel of genes (Nestin,
Sox1, Pax6, GATA4, Foxa2, Sox17, Mixl1 and Brachyury)
associated with the formation of embryonic germ layers
(Fig. 2J).
Based on the fact that the majority of cell types in the adult
body are derived from the germ layer tissues, our ﬁndings sup-
port the pluripotent diﬀerentiation potential of hESCs from an
embryological standpoint, and suggest that early complex
events leading to cell-fate decisions may be recapitulated in
hEBs diﬀerentiated from hESCs in vitro.
3.2. Enhanced neural diﬀerentiation by VEGF, a mitogen of
endothelial cells
During organogenesis, the nervous and vascular systems are
the ﬁrst organs to develop from the germ layer tissues, and
these systems are known to exert a reciprocal paracrine control
of their own growth and diﬀerentiation during embryonicdevelopment [8–14]. Thus, we investigated the possible role
of VEGF, an angiogenic peptide, in neural diﬀerentiation dur-
ing EB formation, the phase in which hESCs begin to develop
toward the neuroectoderm in our system. hEBs were cultured
in the absence (control hEBs) or presence of VEGF (VEGF-
hEBs) for 8 days, and were then analyzed for the expression
of Pax6 and Nestin. Immunostaining analysis demonstrated
that, compared to control hEBs (Fig. 2E–I), VEGF-hEBs con-
tained markedly enlarged neural rosettes that expressed both
Pax6 and Nestin (Fig. 3A). Furthermore, some of the hEBs
were comprised entirely of a thick multicellular layer express-
ing both Pax6 and Nestin, which suggested that the entire
EB might be composed of a thick neuroepithelium (Fig. 3B).
We also asked whether VEGF could promote endothelial or
hematopoietic diﬀerentiation during EB formation. To test
this, we performed immunostaining of the control- and
VEGF-hEBs by using antibody against CD34 at day 8 of EB
formation. Although previous studies using hESCs have
shown the diﬀerentiation of hematopoietic progenitors
[29,30] or vascular organization of CD34+ cells [31] in EBs
treated with a relatively high concentration of serum (20%),
only a few CD34+ cells were detected in control- or VEGF-
hEBs (Fig. 3C) in our serum-free conditions. There was no
apparent diﬀerence in the number of CD34+ cells between con-
trol- and VEGF-hEBs (data not shown), suggesting that
VEGF did not contribute to endothelial speciﬁcation during
this stage of diﬀerentiation in our culture conditions.
To test the possible protective eﬀect of VEGF on neuroecto-
dermal cells, we performed TUNEL and immunostaining anal-
yses on EBs treated with or without VEGF. We found that the
number of TUNEL-positive cells expressing Pax6 or Nestin
Fig. 3. Neuroectodermal diﬀerentiation in hEBs treated with VEGF.
(A) A representative image of VEGF-hEBs containing an enlarged
neural rosette expressing both Pax6 and Nestin. (B) Some of the
VEGF-treated hEB contained a central cavity surrounded by a thick
neuroepithelial cell layer that expressed Pax6 and Nestin. (C) Immu-
nostaining of a VEGF-hEB for CD34. (D) RT-PCR analysis of gene
expressions associated with neuroectodermal (Sox1 and Nestin) and
mesoendodermal (GATA4 and Sox17) diﬀerentiation. Scale bars:
100 lm.
Fig. 4. Enhanced neural diﬀerentiation from VEGF-hEBs. (A, B)
Phase-contrast micrographs of cells migrating out of hEBs after
plating on adherent culture plates. Increased numbers of neural
rosettes were found during the diﬀerentiation of VEGF-hEBs (B)
compared to control hEBs (A). (C) Numbers of neural rosettes at day 8
of diﬀerentiation after plating hEBs that had been generated in the
absence (-VEGF) or presence (+VEGF) of VEGF. Each value
represents the means ± S.E.M. (*P < 0.05, n = 6). (D) VEGF-hEBs
generated string-like structures of neural rosettes. (E) Neural rosettes
generated from VEGF-hEBs expressed Pax2 and Nestin. (F) A
homogeneous population of Nestin+ neural progenitors expanded for
6 days with bFGF after dissociation of neural rosettes. Scale bars:
100 lm (A, B, D, E), 50 lm (F).
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tions (Supplementary Fig. 1), indicating that the increase in
neurogenesis in EBs was not resulted from decreased death
of neuroectodermal cells. The enhanced diﬀerentiation of neu-
roectoderm was further conﬁrmed by RT-PCR analysis.
VEGF treatment increased the expression of Sox1, another
marker of neuroectoderm, and Nestin, at the expense of meso-
dermal or endodermal gene expressions (GATA4 and Sox17)
(Fig. 3D).
The fate of VEGF-hEB was further examined by allowing the
hEBs to reattach to tissue culture plates in ITSmedium [16] con-
taining ﬁbronectin. Over the following 8 days, few of the cells
migrating from the control hEBs showed the expected morphol-
ogy of neural progenitors, although some neural rosettes were
found (Fig. 4A). In contrast, diﬀerentiation of the VEGF-hEBs
resulted in a signiﬁcant increase in the number of neural rosettes
compared to control hEBs (Fig. 4B and C, n = 6, P < 0.05).
Interestingly, string-like structures of neural rosettes, which
were not found in cultures of control hEBs, were often observed
during the diﬀerentiation of VEGF-hEBs (Fig. 4D). Addition-
ally, the columnar cells in the center of nearly all neural rosettes
expressed Pax6 and Nestin, both of which are markers of
neuroectoderm, while most of the cells at the periphery of the
rosettes expressed only Nestin (Fig. 4D). It was previously
known that Pax2 plays a crucial role in patterning the midbrain
and hindbrain [32]. We found that a subset of neural rosettes
contained cells expressing Pax2 (21 ± 3.8% of total cells), and
some of these rosettes were composed entirely of cells that ex-
pressed Pax2 and Nestin (Fig. 4E).
To obtain a high number of neural progenitors, the rosettes
were dissociated with trypsin (0.05%), replated on polyorni-
thine-coated plates and cultured in N2 medium with bFGF(20 ng/ml). Over the following 6 days in this condition, the cells
rapidly proliferated and the majority of cells expressed Nestin
at the end of this stage of proliferation (Fig. 4F). These data
demonstrate that VEGF can promote neuroectodermal diﬀer-
entiation from hESCs, and VEGF-induced neural progenitors
can be further expanded in the presence of bFGF.3.3. Terminal diﬀerentiation into neural cell types
To further investigate the developmental competence of the
neuroectoderm generated by treatment with VEGF, the Nes-
tin+ neural progenitors derived from control- and VEGF-hEBs
were terminally diﬀerentiated into mature neural cell types in
the absence of bFGF for 6 days in N2 medium (Fig. 5A)
and were analyzed by immunostaining using the antibody
against TuJ1 (class III b-tubulin), a neuronal marker.
Although control hEBs generated many cells expressing TuJ1
(43.9 ± 5.2%, n = 5) (Fig. 5B and H), the population of
TuJ1+ cells was signiﬁcantly increased (69.4 ± 3.4%, n = 5,
B.-K. Kim et al. / FEBS Letters 580 (2006) 5869–5874 5873P < 0.05) when hEBs were stimulated with VEGF (Fig. 5C and
H), thus conﬁrming the neurogenic activity of VEGF. GFAP+
astrocytes were rarely observed (Fig. 5D), and cells expressing
O4, a marker of oligodendrocytes, were not detected, suggest-
ing that our culture condition is not favorable for glial diﬀer-
entiation. We also investigated whether our culture condition
promoted vascular diﬀerentiation of hESCs. After terminal
diﬀerentiation, however, very few cells expressing CD34 were
found in either condition, with or without VEGF (Fig. 5E).
This is consistent with our observation that VEGF was not
able to induce vascular diﬀerentiation during EB formation.
Additionally, CD34+ cells were scattered around the area in
which TuJ1+ neurons were not detected, and did not form
an organized vascular structure (Fig. 5E). Because recent stud-
ies showed that factors in serum are crucial for the diﬀerentia-
tion of ESCs to mesoderm, the founder tissue of vascular and
hematopoietic cells [33], we speculate that VEGF alone is not
suﬃcient to promote vascular diﬀerentiation in our serum-free
system.
To characterize the neurons derived from VEGF-hEBs, we
performed immunostaining by using antibodies against vari-
ous neurotransmitters and markers. After 6 days of diﬀerenti-
ation, a high percentage (57.14 ± 3.0%) of TuJ1+ cells
expressed TH (Fig. 5F, n = 5), the rate-limiting enzyme in
dopamine biosynthesis. This eﬃciency of dopaminergic diﬀer-Fig. 5. Terminal diﬀerentiation of VEGF-hEBs into neural cell types. (A) Sch
TuJ1 after terminal diﬀerentiation of control hEBs (B) and VEGF-hEBs (C)
hEBs. (D, E) Cells expressing GFAP (D) or CD34 (E) were rarely found a
diﬀerentiated cells coexpressing TuJ1 and TH (F) and cells expressing GABA
cells derived from EBs treated with or without VEGF. *, P < 0.05, compar
expression of genes associated with the dopaminergic phenotype at the endentiation (approximately 39% of total cells) was signiﬁcantly
higher than that of control cultures (Fig. 5H) and is compara-
ble to those of other reports (35–40% of total cells) using
deﬁned culture conditions or co-culture systems with stromal
cells [34,35]. While a smaller proportion was labeled with
antibody to GABA (<1%) (Fig. 5G), motoneurons
(HB9+TuJ+), serotonin+ neurons and glutamate+ neurons
were not detected.
To further investigate the properties of the hESC-derived
TH+ neurons, we evaluated the expression of speciﬁc genes
involved in dopaminergic neuron development and function.
Nurr1, TH, En-1, and AADC were all expressed after terminal
diﬀerentiation, but DbH, a marker for adrenaline-mediated
neurons was not detected (Fig. 5I). Although additional experi-
ments are required to further characterize the properties and
functions of the neurons, our results suggest that TH+ neurons
derived from VEGF-hEBs may retain the dopaminergic
phenotype.
In summary, our results show that hESCs can rapidly form
EBs that contain the major embryonic and extra-embryonic
cell types of the gastrula, and suggest that application of
VEGF during EB formation signiﬁcantly promotes the gener-
ation of neuroectoderm, which is capable of diﬀerentiating
mainly into neurons that appear to retain the dopaminergic
phenotype. It is thought that mouse ESCs readily acquire aematic procedures of neural diﬀerentiation. (B, C) Immunostaining for
, showing the increased generation of TuJ1+ cells from VEGF-treated
t the end of diﬀerentiation. (F, G) Double immunostaining showing
(G). (H) Bar graph illustrating the percentage of TuJ1- or TH-positive
ed to the control culture (VEGF-). (I) RT-PCR analyses showing the
of terminal diﬀerentiation. Scale bars: 50 lm.
5874 B.-K. Kim et al. / FEBS Letters 580 (2006) 5869–5874neural fate through a default pathway when cells are plated at
limiting dilution densities to avoid cell–cell contacts. Here, our
data suggest that VEGF promotes the neural diﬀerentiation in
EBs which provide a favorable environment for interactions
between diﬀerent cell types or germ layers. Further investiga-
tions will facilitate better understanding of the exact mecha-
nism underlying the neurogenic eﬀect of VEGF.Acknowledgement: This work was supported by a Korea Research
Foundation Grant funded by the Korean government (MOEHRD)
(KRF-2004-003-E00184).Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.febslet.2006.09.
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